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O B J E C T I V E S The aim of this study was to evaluate the progression of atherosclerotic coronary
plaques at bifurcations, using combined intravascular ultrasound–virtual histology (IVUS-VH) and optical
coherence tomography (OCT).
B A C KG ROUND Pathological ﬁndings reveal that atherosclerotic plaques characterized by the pres-
ence of large necrotic cores (NCs) with ﬁbrous cap thicknesses 65 m are more prone to rupture. Accuracy
in the detection of high-risk plaques could be improved by the combined use of IVUS-VH and OCT.
METHOD S IVUS-VH and OCT are 2 imaging modalities with different lateral resolutions and
different depths of penetration. To provide a precise matching of the images, bifurcations were used as
landmarks. IVUS-VH and OCT were performed in 56 bifurcations from 24 patients at baseline and at
6-month follow-up. All patients were treated with standard medical therapy. Bifurcations were studied
at the proximal, in-bifurcation, and distal regions. Plaques were classiﬁed according to their composition
as assessed by IVUS-VH and ﬁbrous cap thickness as quantiﬁed by OCT.
R E S U L T S At baseline, 27 NC-rich plaques were found. At 6-month follow-up, 22 (81%) did not show any
signiﬁcant change. Four new NC-rich lesions developed. At both time points, percent NC was higher and the
ﬁbrous cap was thinner at the proximal bifurcation rim compared with the distal. There were no signiﬁcant
changes in percent NC and ﬁbrous cap thickness in the 3 bifurcation regions between baseline and follow-up
examinations. No major cardiovascular events due to bifurcation lesion progression were observed.
CONC L U S I O N S The combined use of IVUS-VH and OCT is a reliable tool to serially assess plaque
progression and regression, and in the present study it was demonstrated to be safe and feasible. At
6-month follow-up, in this post–percutaneous coronary intervention patient population, most high-risk
plaques remained unchanged, retaining their imaging classiﬁcations, nevertheless appearing to have
remained clinically silent. (J Am Coll Cardiol Img 2011;4:774–80) © 2011 by the American College of
Cardiology Foundation
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775laque rupture and subsequent activation of
the clotting cascade resulting in sudden in-
traluminal thrombosis are thought to be the
most frequent cause of acute coronary syndromes
1,2). In pathology, precursor lesions, known as
hin-cap fibroatheromas (TCFA), are characterized
y a large pool of necrotic core (NC) covered by a
hin fibrous cap 65 m (3). The resolution of
urrent intravascular ultrasound (IVUS) systems
100 to 200 m) constitutes an important limita-
tion of this technique for the measurement of
fibrous cap thickness (4). Optical coherence tomog-
raphy (OCT), in contrast, has higher resolution
(10 to 20 m) but low signal penetration. This
an be a source of inaccurate assessment of NC
ize, especially in plaques with large plaque bur-
en and positive remodeling, which is a charac-
eristic of TCFA lesions (5). Therefore, combin-
Figure 1. Frame Selection at Bifurcations
A strict selection of the analyzed cross-sections was followed to
provide a correct match between the 2 imaging modalities and
between baseline and follow-up. Plaques were analyzed only in
the main coronary arteries at the proximal rim of the ostium of
the side branch (the ﬁrst frame proximal to the takeoff of the
side branch), at the in-bifurcation site (the frame with the larger
ostial diameter of the side branch), and at the distal rim of the
ostium of the side branch (the ﬁrst frame distal to the takeoff of
the side branch).ng the 2 imaging techniques might
rovide a more accurate method to in-
estigate TCFAs (6,7).
There are only a few published reports
f the combined use of IVUS and OCT in
ivo (6,7) and none describing the longi-
udinal assessment of plaque progression
nd regression at bifurcations. The aim of
he present study was therefore to evaluate
erial changes in plaque type and compo-
ition at bifurcations of the main coronary arteries
sing combined IVUS–virtual histology (VH) and
CT.
M E T H O D S
Study population. Fifty-six bifurcations were se-
lected from 24 patients presenting with stable
angina, unstable angina, or silent ischemia. All
patients were treated at the Thoraxcenter, Erasmus
Medical Center (Rotterdam, the Netherlands), and
enrolled in 2 different stent studies (ABSORB
cohort B and SECRITT). Both studies used
IVUS-VH and OCT as part of their protocols.
Table 1. Baseline Clinical Characteristics (n  24)
Age (yrs) 67 (58–73)
Men 19 (79)
Presentation
Stable angina 16 (67)
Unstable angina 5 (20)
Silent ischemia 3 (13)
Hypertension 18 (75)
Hypercholesterolemia 17 (71)
Diabetes 4 (17)
Smoking 5 (20)
Family history of CAD 13 (54)
Previous AMI 9 (37)
Previous PCI 10 (42)
Vessel
LAD 11(46)
LCX 5 (20)
RCA 8 (33)
Therapy
Antiplatelet therapy 24 (100)
Beta-blockers 15 (62)
ACE inhibitors/ARBs 13 (54)
Statins 16 (67)
Insulin 1 (4)
Values are median (interquartile range) or n (%).
ACE  angiotensin-converting enzyme; AMI  acute myocardial infarction;
ARB  angiotensin II receptor blocker; CAD  coronary artery disease; LAD 
left anterior descending coronary artery; LCX  left circumﬂex coronary
artery; PCI  percutaneous coronary intervention; RCA  right coronary
A B B
A N D
IVUS
NC
OCT
tomog
TCFA
VHartery.R E V I A T I O N S
A C R O N YM S
 intravascular ultrasound
necrotic core
optical coherence
raphy
 thin-cap fibroatheroma
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776Table 2. Geometrical and Compositional Data in Each Region of the Bifurcation at Baseline and Follow-Up
Variable Baseline Follow-Up p Value
Vessel CSA (mm2)
Distal 14.01 (10.75–18.06) 13.52 (10.32–16.49) 0.051
In-bifurcation 15.62 (12.47–20.14) 14.75 (12.11–18.77) 0.543
Proximal 15.84 (12.86–20.85) 14.89 (12.23–20.83) 0.262
Luminal CSA (mm2)
Distal 7.23 (6.19–9.27) 7.20 (6.19–9.27) 0.012
In-bifurcation 8.46 (7.25–11.05) 7.93 (7.04–10.68) 0.184
Proximal 7.62 (6.80–9.85) 7.27 (6.00–9.75) 0.005
Plaque CSA (mm2)
Distal 5.68 (3.74–8.50) 6.26 (4.07–8.30) 0.231
In-bifurcation 5.79 (3.93–8.23) 6.07 (4.36–8.96) 0.144
Proximal 6.84 (5.11–10.72) 7.54 (6.00–10.86) 0.046
Plaque burden (%)
Distal 42.74 (33.30–57.12) 49.13 (36.61–57.87) 0.004
In-bifurcation 39.38 (30.30–48.86) 42.76 (34.37–48.42) 0.027
Proximal 48.67 (39.32–58.69) 51.50 (46.39–59.54) 0.008
Minimal luminal diameter (mm)
Distal 2.80 (2.44–3.24) 2.65 (2.29–3.18) 0.007
In-bifurcation 2.87 (2.56–3.21) 2.77 (2.48–3.29) 0.033
Proximal 2.90 (2.60–3.28) 2.78 (2.47–3.16) 0.039
Minimal vessel diameter (mm)
Distal 3.95 (3.48–4.54) 3.88 (3.41–4.31) 0.075
In-bifurcation 4.06 (3.77–4.59) 4.06 (3.61–4.45) 0.489
Proximal 4.22 (3.81–4.69) 4.13 (3.71–4.72) 0.194
Fibrous CSA (mm2)
Distal 1.33 (0.13–3.23) 1.44 (0.45–2.72) 0.423
In-bifurcation 1.53 (0.52–2.83) 1.48 (0.94–2.96) 0.368
Proximal 1.65 (1.20–4.20) 2.57 (1.31–3.49) 0.329
Fibrous tissue (%)
Distal 60.36 (40.41–70.90) 61.03 (50.83–68.17) 0.922
In-bifurcation 62.63 (50.21–69.14) 59.68 (52.75–66.83) 0.094
Proximal 58.85 (51.09–69.24) 58.18 (50.65–64.23) 0.150
Fibrofatty CSA (mm2)
Distal 0.18 (0.02–0.75) 0.30 (0.03–0.87) 0.498
In-bifurcation 0.26 (0.06–0.68) 0.29 (0.07–0.72) 0.739
Proximal 0.50 (0.18–1.09) 0.45 (0.23–1.16) 0.870
Fibrofatty tissue (%)
Distal 10.54 (1.56–18.02) 10.47 (6.07–18.88) 0.299
In-bifurcation 10.99 (5.24–16.78) 10.55 (3.79–18.84) 0.504
Proximal 13.12 (6.24–23.88) 10.46 (5.53–18.48) 0.339
NC CSA (mm2)
Distal 0.19 (0.02–0.62) 0.39 (0.06–0.82) 0.374
In-bifurcation 0.38 (0.05–0.70) 0.50 (0.12–0.88) 0.089
Proximal 0.44 (0.44–0.13) 0.62 (0.28–1.28) 0.265
NC (%)
Distal 9.90 (1.79–18.13) 13.95 (7.42–21.94) 0.261
In-bifurcation 12.31 (6.52–18.15) 16.10 (8.81–21.65) 0.199
Proximal 12.44 (5.92–23.15) 16.24 (8.65–20.43) 0.280Continued on next page
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777The bifurcations selected for this study were
more than 5 mm away from the stented region and
had side branch orifice diameters 1.5 mm as
measured by OCT. Only bifurcations imaged with
both modalities and for which imaging was of high
quality were considered. All bifurcations fitting this
inclusion criteria were included. All patients re-
ceived standard medical therapy, including aspirin,
clopidogrel, and statins, for at least 6 months.
IVUS-VH acquisition and analysis. IVUS acquisitions
ere performed using an Eagle Eye catheter (Vol-
ano Corporation, Rancho Cordova, California)
ith automatic continuous pullback at a speed of
.5 mm/s. IVUS grayscale and IVUS-VH analyses
ere performed offline using dedicated software (8).
OCT acquisition. The OCT M3 (Time Domain-
OCT) and C7 (Fourier Domain-OCT) systems
were used in this study (LightLab Imaging, Inc.,
Westford, Massachusetts). For each patient, the
same system was used for baseline and follow-up
examinations. Measurements were performed of-
fline by 2 independent observers using LightLab
imaging software.
OCT analysis. Fibrous cap thickness measurement
was performed in each bifurcation frame at the
thinnest part of the fibrous cap overlying the pool of
NC. The reproducibility of this variable has been
previously reported by our group (9).
Bifurcation matching analysis. IVUS-VH and OCT
are 2 imaging modalities with different lateral resolu-
tions and different depths of penetration. To provide a
precise matching of the images, a strict selection of
frames was followed using a method previously de-
scribed (7). Only the main branches were analyzed,
and for each bifurcation the following frames were
considered: 1) the proximal rim of the side branch
ostium; 2) the in-bifurcation site (the frame with the
largest ostial diameter of the side branch); and 3) the
Table 2. Continued
Variable Baseline
Dense calcium CSA (mm2)
Distal 0.08 (0.00–0.42
In-bifurcation 0.10 (0.01–0.48
Proximal 0.17 (0.02–0.53
Dense calcium (%)
Distal 3.29 (0.00–9.52
In-bifurcation 6.70 (0.46–13.8
Proximal 3.74 (0.92–9.86
Values are median (interquartile range).
CSA  cross-sectional area; NC  necrotic core.distal rim of the side branch ostium (Fig. 1).Plaque type classiﬁcation. Plaques were classified ac-
cording to the following previously described (7)
hierarchical classification: 1) those with high percents
of fibrotic tissue (adaptive intimal thickening, patholog-
ical intimal thickening, fibrotic plaque, and fibrocalcific
plaque); and 2) NC-rich plaques (those with more than
10% confluent NC) (fibroatheroma and calcified fibro-
atheroma); if covered by fibrous caps thinner than 65
m, they constitute TCFA and calcified TCFA.
These plaque types are reported per location
within the bifurcation (at the distal, in-bifurcation,
and proximal frames) and per bifurcation, defined
as the worst plaque type within the bifurcation
detected among the 3 frames considered.
In addition, we introduce an IVUS-VH and
OCT–derived plaque risk index, defined as the
ratio between the sum of NC-rich plaques and the
sum of non-NC-rich plaques in a given bifurcation
region. This index was calculated for each bifurca-
tion region at both baseline and follow-up.
Statistical analysis. Categorical variables are pre-
ented as frequencies and percents. Continuous
ariables are presented as medians and interquartile
anges and were compared using the Wilcoxon
igned rank test. A p value 0.05 was considered
tatistically significant. The bifurcation was the unit
f analysis, without correction for correlated obser-
ations in the same subjects. Statistical analyses
ere performed using SPSS version 16.0 for Win-
ows (SPSS, Inc., Chicago, Illinois).
R E S U L T S
Patients’ baseline clinical characteristics are re-
ported in Table 1. The median age was 67 years,
and most patients were men (79%). At follow-up,
all patients were treated with statins: 6 received
rosuvastatin (4 received 10 mg and 2 received 20
Follow-Up p Value
0.20 (0.00–0.40) 0.021
0.20 (0.01–0.40) 0.005
0.30 (0.01–0.70) 0.002
4.87 (0.43–15.71) 0.031
7.62 (1.74–13.30) 0.124
6.60 (1.89–14.55) 0.003)
)
)
)
5)
)mg), 9 patients received simvastatin (7 received 20
2
v
pathologic
virtual histology.
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778mg and 2 received 40 mg), and 9 patients received
atorvastatin (6 received 40 mg, 2 received 20 mg,
and 1 received 10 mg).
Results from the geometrical and compositional
analysis at the distal rim, in-bifurcation, and proximal
rim of the side branch ostium are reported in Table 2.
At follow-up, the median vessel cross-sectional
area remained unchanged at the distal, in-
bifurcation, and proximal frames, while median
luminal cross-sectional area decreased slightly, re-
sulting in an increase in plaque burden (Table 2).
Fibrous and fibrofatty tissue did not change
between baseline and follow-up. Median NC cross-
Changes in Bifurcation Plaque Type
bifurcation plaque type at 6-month follow-up. For each plaque
ercent of changes is reported. AIT  adaptive intimal thickening;
lciﬁed ﬁbroatheroma; CaTCFA  calciﬁed thin-cap ﬁbroatheroma;
atheroma; FC  ﬁbrocalciﬁc plaque; FT  ﬁbrotic plaque; PIT 
at Distal Rim, In-Bifurcation, and Proximal Rim at Baseline and F
Non–NC-Rich Plaques
AIT PIT FT FC FA
23 (41) 4 (7.1) 9 (16.1) 3 (5.4) 6 (10.7
19 (33.9) 6 (10.7) 10 (17.9) 2 (3.6) 5 (8.9)
17 (30.4) 4 (7.1) 9 (16.1) 7 (12.5) 7 (12.5
12 (21.4) 6 (10.7) 8 (14.3) 8 (14.3) 9 (16.1
14 (25.0) 5 (8.9) 7 (12.5) 6 (10.7) 6 (10.7
8 (14.3) 7 (12.5) 9 (16.1) 5 (8.9) 6 (10.7
NC-rich/non-NC-rich plaques.
ickening; BL  baseline; CaFA  calciﬁed ﬁbroatheroma; CaTCFA  calciﬁed th
US intravascular ultrasound; NC necrotic core; OCT optical coherence tomoal intimal thickening; TCFA  thin-cap ﬁbroatheroma.sectional area and percent NC nonsignificantly
increased in each region. Dense calcium cross-
sectional area significantly increased at the distal,
in-bifurcation, and proximal segment (Table 2).
In NC-rich plaques (NC  10% [fibroatheroma,
calcified fibroatheroma, TCFA, and calcified
TCFA]), the percent of NC nonsignificantly de-
creased over time at the distal rim (21.65% vs.
18.54%, p  0.193), in-bifurcation (22.38% vs.
0.25%, p  0.573), and proximal rim (23.15%
s. 18.06%, p  0.317).
Distribution of IVUS-VH and OCT–derived plaque types
at the 3 bifurcation regions. The distribution of
NC-rich and NC-poor plaques is presented in
Table 3. There was a gradient of disease from the
proximal to the distal rim. NC-rich plaques were
more frequently located at the proximal rim. Non–
NC-rich plaques showed an inverse gradient. In addi-
tion, the highest value of the IVUS-VH and OCT–
derived plaque risk index was found in the proximal rim
of the bifurcations at both baseline and follow-up. From
baseline to follow-up, the index increased in each region,
implying that the number of NC regions relative to
non-NC regions also increased (Table 3).
Bifurcation plaque types. At baseline, 27 NC-rich
plaques were found, of which 6 were classified as
thin-cap lesions (TCFA and calcified TCFA). Two
fibroatheroma plaques became fibrotic and fibrocal-
cific (regressed), and 1 TCFA became a fibroathe-
roma (regressed). Two fibroatheromas became
TCFAs (progressed), and 22 (81%) did not change.
Four new NC-rich lesions developed from fibrotic
and fibrocalcific plaques. Most (83%) thin-cap le-
sions did not change at 6-month follow-up (Fig. 2).
Fibrous cap thickness, distribution, and changes over
time. Fibrous cap thickness significantly decreased
from the distal to the proximal region at both
baseline and follow-up (Fig. 3). However, no
w-Up and IVUS-VH and OCT–Derived Plaque Risk Index
NC-Rich Plaques
CaFA TCFA CaTCFA Plaque Risk Index*
10 (17.9) 0 (0) 1 (1.8) 17/39  0.43
12 (21.4) 0 (0) 2 (3.6) 19/37  0.51
10 (17.9) 0 (0) 2 (3.6) 19/37  0.51
10 (17.9) 1 (1.8) 2 (3.6) 22/34  0.65
12 (21.4) 2 (3.6) 4 (7.1) 24/32  0.75
14 (25.0) 1 (1.8) 6 (10.7) 27/29  0.93
p ﬁbroatheroma; FA  ﬁbroatheroma; FC  ﬁbrocalciﬁc plaque; FT  ﬁbrotic
hy; PIT pathological intimal thickening; TCFA thin-cap ﬁbroatheroma; VHFigure 2.
Changes in
type, the p
CaFA  ca
FA  ﬁbroTable 3. Plaque Type ollo
Segment
Distal rim BL )
Distal rim FU
In-bifurcation BL )
In-bifurcation FU )
Proximal rim BL )
Proximal rim FU )
Values are n (%). *Sum of
AIT  adaptive intimal th in-ca
plaque; FU follow-up; IV grapchanges in cap thickness were observed from base-
bas
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779line to follow-up within each of the 3 regions
(Table 4, Fig. 4). The same held for frames with
thin-cap lesions, for which no changes in cap
thickness were observed over time (Table 4).
D I S C U S S I O N
The main findings of our study are as follows:
1) dual-modality acquisition and analysis at 2 dif-
ferent time points for the evaluation of coronary
atherosclerosis is feasible, addressing the comple-
mentary limitations of the 2 imaging modalities. 2)
In a post–percutaneous coronary intervention pa-
tient population treated with standard medical ther-
apy, most NC-rich plaques remained unchanged in
their composition as measured by IVUS-VH at
6-month follow-up, and most thin-cap lesions re-
mained thin capped (65 m) as measured by
OCT. 3) Although the study population was small,
the serial imaging findings of plaque morphology
were in line with the clinical outcomes.
Figure 3. Fibrous Cap Thickness in the Three Regions of the Bif
The ﬁbrous cap was measured in each frame with a plaque more t
with more than 10% of conﬂuent necrotic core detected by intrava
sive reduction in thickness from the distal to the proximal frame at
Table 4. Minimal Fibrous Cap Thickness at Distal,
In-Bifurcation, and Proximal Segments in All NC-Rich Plaques
NC-Rich
Plaques Segment
Baseline
(m)
Follow-Up
(m)
p
Value
Non–thin-cap
lesions
Distal 100 (80–130) 90 (70–110) 0.206
In-bifurcation 80 (70–100) 80 (60–100) 0.670
Proximal 70 (50–90) 70 (60–100) 0.065
Thin-cap
lesions
Distal 50 (40–50) 70 (40–90) 0.317
In-bifurcation 50 (40–60) 50 (40–50) 0.564
Proximal 50 (40–60) 50 (50–60) 0.084
Values are median (interquartile range).
NC  necrotic core.Moreover, we observed that the proximal rim of
the side branch ostium is more likely to contain a
larger amount of NC and the thinnest fibrous cap
within the bifurcation.
The plaque index, defined as the ratio of NC-rich
to non-NC-rich frames, increased, implying
a progression of the disease at 6 months. This finding
is supported by the observation that in this small
series, 4 new NC-rich plaques developed and 2 addi-
tional plaques became TCFAs. This progression was
due mostly to an increase of NC in non–NC-rich
plaques (development of new NC-rich areas).
To our knowledge, this is the first in vivo study
evaluating longitudinal changes in plaque type and
tion
600 m thick assessed by optical coherence tomography and
ar ultrasound–virtual histology. The ﬁbrous cap showed a progres-
eline (A) and follow-up (B).
Figure 4. Thin Fibrous Cap at Baseline and Follow-Up
Thin ﬁbrous cap did not show a statistically signiﬁcant differ-
ence in cap thickness at 6-month follow-up (red arrows). The
matching of the frames was done using bifurcations and alsourca
han
sculmicrostructures (white arrows) as landmarks.
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780composition using combined plaque assessment
with IVUS-VH and OCT.
Sawada et al. (6) recently reported in a small series
that 54% of IVUS-VH–derived TCFAs were non-
thin-cap lesions by OCT, and 6.3% of OCT-derived
TCFAs were not definitively TCFAs. This study
strongly supports the combined use of these 2
imaging modalities, which appears to be neces-
sary for the correct detection of high-risk
plaques. In addition, Manfrini et al. (5) reported
that if used alone, OCT can lead to misinterpretations
due to its low signal penetration, which does not allow an
accurate detection of signal-poor areas with heteroge-
neous compositions.
Previously, Kubo et al. (10) reported in a serial popu-
lation that 75% of TCFAs detected on VH healed at
1-year follow-up. Takarada et al. (11) reported that
therapy with statins significantly increased fibrous cap
thickness detected with OCT in a population with
untreated hypercholesterolemia. However, potentially all
single-modality imaging studies could have obtained
different results by combining the 2 modalities, virtually
increasing accuracy for TCFA detection.
Therefore, further investigations are needed to bet-
ter understand the evolution of high-risk plaques in
patients with optimal medical treatment, and the com-
bined use of IVUS-VH and OCT could be a key tool toplaque morphology by optical coher-
E. Assessment of c
coronary narrowingStudy limitations. This study might have been under-
owered to detect differences in plaque composition,
nd the length of follow-up was short, so the study
hould be considered exploratory and hypothesis gen-
rating, without formal statistical hypotheses.
Local endothelial shear stress was not measured.
e cannot exclude that different plaque progres-
ion and regression might be also associated in the
resent series to different shear stress conditions.
ecause the BVS (Abbott Laboratories, Abbott
ark, Illinois) is a drug-eluting device, in bifurca-
ions located distally to the scaffold, the drug might
ave a considerable impact on the progression or
egression of atherosclerosis.
C O N C L U S I O N S
The combined use of IVUS-VH and OCT is a
reliable tool to serially assess plaque progression and
regression, and in the present study, it was demon-
strated to be safe and feasible. At 6-month follow-up,
in this post–percutaneous coronary intervention pa-
tient population, most high-risk plaques remained
unchanged, retaining their imaging classification, nev-
ertheless appearing to have remained clinically silent.
Reprint requests and correspondence: Dr. Patrick W. Ser-
uys, Erasmus Medical Center, ’s-Gravendijkwal 230,
015 CE Rotterdam, the Netherlands. E-mail: p.w.j.characterize the coronary model of future events (12). c.serruys@erasmusmc.nl.1
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